FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 72329

News■ Unclear/unknown

TRex Bio raises $117M in Nasdaq IPO at $14 a share

KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-09 02:17 UTC
LAST UPDATE2026-10-09 02:17 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

A small biotech IPO pricing at $14 signals some risk appetite for early-stage healthcare listings, but scale is minimal.

Tiny biotech listing, marginal sentiment read
CATALYST TO WATCH

First-day trading performance

MAIN RISK

Small deal, weak signal for broader IPO market

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01googlenewsnews.google.com · PRIMARY2026-10-09 02:17 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.